Lipocine LPCN Income Statement (2011-2025)

NASDAQ LPCN
$2.09 +0.04 (+1.95%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.06M16.09M0.50M0.05M3.12M-0.22M7.62M0.09M3.49M0.09M0.62M0.11M
Operating items
Research & Development (Quarter)
1.58M1.46M2.37M2.25M1.89M2.90M2.10M1.67M3.11M2.52M2.88M1.67M2.82M1.87M1.59M1.07M1.06M2.14M2.71M
Selling, General & Administrative (Quarter)
1.53M1.53M1.22M1.05M1.24M1.13M0.80M0.89M1.29M1.44M1.04M1.13M1.58M1.51M1.05M0.87M1.12M0.89M0.77M
Restructuring Costs (Quarter)
4.00M
Other Operating Expenses (Quarter)
-4.00M0.25M
Operating Expenses (Quarter)
3.11M2.99M3.59M3.30M3.13M4.03M2.90M2.56M4.39M3.96M3.92M2.81M4.39M3.38M2.63M1.95M2.18M3.03M3.48M
Operating Income (Quarter)
-3.11M-2.99M-3.53M12.78M-3.13M-3.53M-2.90M-2.56M-4.34M-3.96M-7.04M-2.59M3.22M-3.29M-2.63M1.55M-2.09M-2.40M-3.36M
EBIT (Quarter)
-3.11M-2.99M-3.53M12.78M-3.13M-3.53M-2.90M-2.56M-4.34M-3.96M-7.04M-2.59M3.22M-3.29M-2.63M1.55M-2.09M-2.40M-3.36M
Non-operating items
Interest & Investment Income (Quarter)
-0.02M0.02M0.02M0.02M-0.05M0.07M0.16M0.30M0.37M0.38M0.32M0.30M0.33M0.31M0.27M0.23M0.23M0.20M0.17M
Other Non Operating Income (Quarter)
-0.25M-3.82M0.48M-0.16M-0.38M0.58M0.33M0.03M0.10M0.03M0.07M0.23M-0.04M-0.08M0.14M0.47M
Non Operating Income (Quarter)
0.90M0.49M0.33M0.47M0.41M0.39M0.31M0.29M0.22M0.41M0.24M0.23M0.20M0.17M
Net income details
EBT (Quarter)
-3.37M-6.81M-3.08M12.62M-3.49M-2.63M-2.41M-2.23M-3.87M-3.55M-6.65M-2.28M3.51M-3.07M-2.22M1.78M-1.86M-2.21M-3.19M
Tax Provisions (Quarter)
200.00-0.13M200.00-2.26M200.00-3.43M200.00481.000.00M200.00
Profit After Tax (Quarter)
-3.39M-6.81M-3.08M12.61M-3.54M-2.65M-2.74M-2.26M-3.97M-3.58M-6.73M-2.29M3.55M-3.07M-2.36M1.80M-1.87M-2.21M-3.19M
Income from Continuing Operations (Quarter)
-3.37M-6.81M-3.08M12.76M-3.49M-2.63M-2.41M0.03M-3.87M-3.55M-6.65M1.15M3.51M-3.07M-2.22M1.78M-1.86M-2.21M-3.19M
Consolidated Net Income (Quarter)
-3.37M-6.81M-3.08M12.76M-3.49M-2.63M-2.41M0.03M-3.87M-3.55M-6.65M1.15M3.51M-3.07M-2.22M1.78M-1.86M-2.21M-3.19M
Income towards Parent Company (Quarter)
-3.37M-6.81M-3.08M12.76M-3.49M-2.63M-2.41M0.03M-3.87M-3.55M-6.65M1.15M3.51M-3.07M-2.22M1.78M-1.86M-2.21M-3.19M
Preferred Dividend Payments (Quarter)
89.00
Net Income towards Common Stockholders (Quarter)
-3.37M-6.81M-3.08M12.62M-3.49M-2.63M-2.41M-2.23M-3.87M-3.55M-6.65M-2.28M3.51M-3.07M-2.22M1.78M-1.86M-2.21M-3.19M
Additional items
EPS (Basic) (Quarter)
-0.70-1.31-0.592.47-0.67-0.51-0.46-0.43-0.74-0.68-1.26-0.430.66-0.57-0.410.33-0.35-0.41-0.59
EPS (Diluted) (Quarter)
-0.70-1.31-0.592.47-0.67-0.50-0.46-0.43-0.74-0.68-1.26-0.430.66-0.57-0.410.33-0.35-0.41-0.59
Shares Outstanding (Quarter)
4.82M5.19M5.19M5.11M5.19M5.21M5.21M5.20M5.21M5.23M5.29M5.27M5.32M5.34M5.35M5.34M5.35M5.35M5.41M5.41M
Shares Outstanding (Diluted) (Quarter)
4.82M5.19M5.19M5.11M5.19M5.23M5.22M5.23M5.21M5.23M5.29M5.27M5.36M5.34M5.35M5.42M5.35M5.35M5.41M5.41M
Shares Outstanding (Entity) (Quarter)
5.19M5.19M5.19M5.19M5.21M5.21M5.21M5.21M5.21M5.23M5.32M5.32M5.32M5.35M5.35M5.35M5.35M5.37M5.42M6.16M
EBITDA (Quarter)
-3.11M-2.99M-3.53M12.78M-3.13M-3.53M-2.90M-2.56M-4.34M-3.96M-7.04M-2.59M3.22M-3.29M-2.63M1.55M-2.09M-2.40M-3.36M
Interest Expenses (Quarter)
0.82M0.64M0.38M0.02M0.67M0.23M0.14M0.07M0.33M0.24M0.15M0.00M0.04M0.23M0.01M0.44M0.35M0.25M0.16M
Tax Rate (Quarter)
-0.01%-1.06%-0.01%101.35%-0.01%150.51%0.01%-0.02%0.07%-0.01%